TrialBMC psychiatry2022

Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials.

Yuichi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.